Evidence map›Paper›PMID 31473331›Full record

ArticleContemporary clinical trials2019

A randomized controlled trial of a smoking cessation self-help intervention for Spanish-speaking Hispanic/Latinx smokers: Study design and baseline characteristics.

Patricia Medina-Ramírez, Steven K Sutton, Úrsula Martínez, Cathy D Meade, Margaret M Byrne, Karen O Brandon, Lauren R Meltzer, Fiorella M Gonzales, Thomas H Brandon, Vani N Simmons

Open access · greenAbstract readClinical Trial Protocol
In one paragraph

Article in Contemporary clinical trials, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Interventions for improving health literacy in migrants.The Cochrane database of systematic reviews · 2023
    Pooled it
  2. Hispanic/Latinx Ethnic Subgroup Differences in Sociodemographic, Sociocultural, and Smoking Characteristics in a Cessation Trial: An Exploratory Study.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2022
    Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Patricia Medina-RamírezH. Lee Moffitt Cancer Center, Tampa, FL, USA.
Steven K SuttonH. Lee Moffitt Cancer Center, Tampa, FL, USA; University of South Florida, USA.
Úrsula MartínezH. Lee Moffitt Cancer Center, Tampa, FL, USA.
Cathy D MeadeH. Lee Moffitt Cancer Center, Tampa, FL, USA; University of South Florida, USA.
Margaret M ByrneH. Lee Moffitt Cancer Center, Tampa, FL, USA; University of South Florida, USA.
Karen O BrandonH. Lee Moffitt Cancer Center, Tampa, FL, USA.
Lauren R MeltzerH. Lee Moffitt Cancer Center, Tampa, FL, USA.
Fiorella M GonzalesH. Lee Moffitt Cancer Center, Tampa, FL, USA.
Thomas H BrandonH. Lee Moffitt Cancer Center, Tampa, FL, USA; University of South Florida, USA.
Vani N SimmonsH. Lee Moffitt Cancer Center, Tampa, FL, USA; University of South Florida, USA. Electronic address: Vani.Simmons@Moffitt.org.
Moffitt Cancer Center · USUniversity of South Florida · US

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI John L. Cleveland · 1998 to 2026
$93.5M
Expanding the Reach of a Validated Smoking-Cessation Intervention: A Spanish-language RCTR01CA199143 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI SIMMONS, VANI N · 2016 to 2020
$2.8M
NCI NIH HHS P30 CA076292NCI NIH HHS R01 CA199143
6 · The paper itself

Abstract

Although the current smoking prevalence among Hispanics/Latinxs (10%) is lower than in non-Hispanic whites (15%), higher prevalence is observed among certain subgroups (e.g., Puerto Rican males, 19%). Hispanic/Latinx smokers face unique challenges such as lower awareness and acceptability of nicotine replacement aids, lower prevalence of using counseling or medication, and receiving less advice to quit by their health care providers. Despite these barriers to smoking cessation, few interventions specifically targeted to Hispanic/Latinx smokers have been developed and evaluated. This paper summarizes the design, methods, analysis plan, and sample baseline characteristics of an ongoing randomized controlled trial to assess the efficacy of a Spanish-language self-help smoking cessation intervention among Hispanics/Latinxs. Current smokers who prefer health education materials in Spanish were randomized to one of two conditions. The usual care group received a standard smoking cessation booklet developed by the National Cancer Institute. The intervention group received 10 booklets, 9 pamphlets and a booklet for family and friends mailed monthly over 18 months. All participants complete self-report surveys every 6 months over 2 years. Smoking abstinence is biochemically verified at 12- and 24-month follow-up. A total of 2387 smokers were screened, 2056 were eligible and 1417 were enrolled in the study. The primary outcome is self-reported 7-day point prevalence abstinence. If the intervention is deemed efficacious, it has potential to have a large public health impact with respect to reducing smoking rates and smoking related morbidity and mortality among a large underserved minority population.

Indexed as

Hispanic or LatinoFemaleHumansMaleMiddle AgedPatient Education as TopicProgram EvaluationRandomized Controlled Trials as TopicResearch DesignSelf-ManagementSmoking CessationHispanicLatinoRandomized controlled trialSelf-help interventionSmoking cessation interventionTobacco cigarette

Identifiers

PMID31473331
PMCPMC6815731
OpenAlexW2970632310

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.